Figure 1: Fasting plasma
glucose levels at 2 and 16 weeks of treatment. D+A; diabetic mice
treated with Vitamin A. *P<0.05 compared to control
nondiabetic mice.
Fasting blood insulin levels were examined at week 2 and week 16
post-injection. Elevated blood insulin levels (9.3 ± 7.1 mM) were
observed at the third day post-injection. At two weeks both untreated
and treated diabetic mice showed a significant increase in fasting
insulin levels (9.8 ± 8.7 mM, 9.7 ± 7.5 mM,P < 0.05, respectively) compared with that of normal
mice. At 16 weeks both untreated and treated diabetic mice still showed
a significant increase in their fasting insulin levels (9.7 mM ± 7.7,
8.9± 8.3 mM, P < 0.05, respectively) compared with
that of normal mice (Figure 2).